AAAAAA

   
Results: 1-14 |
Results: 14
Delayed emergence of bovine leukemia virus after vaccination with a protective cytotoxic T cell-based vaccine
Authors: Mateo, L Gardner, J Suhrbier, A
Citation: L. Mateo et al., Delayed emergence of bovine leukemia virus after vaccination with a protective cytotoxic T cell-based vaccine, AIDS RES H, 17(15), 2001, pp. 1447-1453
Cytotoxic T cell polyepitope vaccines delivered by ISCOMs
Authors: Le, TTT Drane, D Malliaros, J Cox, JC Rothel, L Pearse, M Woodberry, T Gardner, J Suhrbier, A
Citation: Ttt. Le et al., Cytotoxic T cell polyepitope vaccines delivered by ISCOMs, VACCINE, 19(32), 2001, pp. 4669-4675
Immune responses to ISCOM (R) formulations in animal and primate models
Authors: Sjolander, A Drane, D Maraskovsky, E Scheerlinck, JP Suhrbier, A Tennent, J Pearse, M
Citation: A. Sjolander et al., Immune responses to ISCOM (R) formulations in animal and primate models, VACCINE, 19(17-19), 2001, pp. 2661-2665
Arbovirus of marine mammals: a new alphavirus isolated from the elephant seal louse, Lepidophthirus macrorhini
Authors: Linn, ML Gardner, J Warrilow, D Darnell, GA McMahon, CR Field, I Hyatt, AD Slade, RW Suhrbier, A
Citation: Ml. Linn et al., Arbovirus of marine mammals: a new alphavirus isolated from the elephant seal louse, Lepidophthirus macrorhini, J VIROLOGY, 75(9), 2001, pp. 4103-4109
Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A0201 transgenic, H-2 class IKO mice
Authors: Firat, H Tourdot, S Ureta-Vidal, A Scardino, A Suhrbier, A Buseyne, F Riviere, Y Danos, O Michel, ML Kosmatopoulos, K Lemonnier, FA
Citation: H. Firat et al., Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A0201 transgenic, H-2 class IKO mice, EUR J IMMUN, 31(10), 2001, pp. 3064-3074
Asymptomatic primary Epstein-Barr virus infection occurs in the absence ofblood T-cell repertoire perturbations despite high levels of systemic viral load
Authors: Silins, SL Sherritt, MA Silleri, JM Cross, SM Elliott, SL Bharadwaj, M Le, TTT Morrison, LE Khanna, R Moss, DJ Suhrbier, A Misko, LS
Citation: Sl. Silins et al., Asymptomatic primary Epstein-Barr virus infection occurs in the absence ofblood T-cell repertoire perturbations despite high levels of systemic viral load, BLOOD, 98(13), 2001, pp. 3739-3744
An arthrogenic alphavirus induces monocyte chemoattractant protein-1 and interleukin-8
Authors: Mateo, L La Linn, M McColl, SR Cross, S Gardner, J Suhrbier, A
Citation: L. Mateo et al., An arthrogenic alphavirus induces monocyte chemoattractant protein-1 and interleukin-8, INTERVIROLO, 43(1), 2000, pp. 55-60
Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines
Authors: Sherritt, MA Gardner, J Elliott, SL Schmidt, C Purdie, D Deliyannis, G Heath, WR Suhrbier, A
Citation: Ma. Sherritt et al., Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines, EUR J IMMUN, 30(2), 2000, pp. 671-677
Peptide based cytotoxic T-cell vaccines; delivery of multiple epitopes, help, memory and problems
Authors: Elliott, SL Pye, S Le, T Mateo, L Cox, J Macdonald, L Scalzo, AA Forbes, CA Suhrbier, A
Citation: Sl. Elliott et al., Peptide based cytotoxic T-cell vaccines; delivery of multiple epitopes, help, memory and problems, VACCINE, 17(15-16), 1999, pp. 2009-2019
Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity
Authors: Ramsay, AJ Kent, SJ Strugnell, RA Suhrbier, A Thomson, SA Ramshaw, IA
Citation: Aj. Ramsay et al., Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity, IMMUNOL REV, 171, 1999, pp. 27-44
Picornavirus receptor down-regulation by plasminogen activator inhibitor type 2
Authors: Shafren, DR Gardner, J Mann, VH Antalis, TM Suhrbier, A
Citation: Dr. Shafren et al., Picornavirus receptor down-regulation by plasminogen activator inhibitor type 2, J VIROLOGY, 73(9), 1999, pp. 7193-7198
Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIVCD8(+) cytotoxic T-cell epitopes
Authors: Woodberry, T Gardner, J Mateo, L Eisen, D Medveczky, J Ramshaw, IA Thomson, SA French, RA Elliot, SL Firat, H Lemonnier, FA Suhrbier, A
Citation: T. Woodberry et al., Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIVCD8(+) cytotoxic T-cell epitopes, J VIROLOGY, 73(7), 1999, pp. 5320-5325
An HLA-A2 polyepitope vaccine for melanoma immunotherapy
Authors: Mateo, L Gardner, J Chen, QY Schmidt, C Down, M Elliott, SL Pye, SJ Firat, H Lemonnier, FA Cebon, J Suhrbier, A
Citation: L. Mateo et al., An HLA-A2 polyepitope vaccine for melanoma immunotherapy, J IMMUNOL, 163(7), 1999, pp. 4058-4063
H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies
Authors: Firat, H Garcia-Pons, F Tourdot, S Pascolo, S Scardino, A Garcia, Z Michel, ML Jack, RW Jung, G Kosmatopoulos, K Mateo, L Suhrbier, A Lemonnier, FA Langlade-Demoyen, P
Citation: H. Firat et al., H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies, EUR J IMMUN, 29(10), 1999, pp. 3112-3121
Risultati: 1-14 |